Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 21,426,000 | 18,849,000 | 17,841,000 | 16,663,000 | 18,298,000 |
| Cost of Goods | 5,150,000 | 4,469,000 | 4,520,000 | 4,490,000 | 5,491,000 |
| Gross Profit | 16,276,000 | 14,380,000 | 13,321,000 | 12,173,000 | 12,807,000 |
| Operating Expenses | 11,506,000 | 10,469,000 | 9,558,000 | 8,908,000 | 9,586,000 |
| Operating Income | 4,770,000 | 3,911,000 | 3,763,000 | 3,265,000 | 3,221,000 |
| Interest Expense | 0 | 0 | 0 | 105,000 | 135,000 |
| Other Income | 315,000 | 291,000 | 274,000 | 917,000 | 761,000 |
| Pre-tax Income | 5,085,000 | 4,202,000 | 4,037,000 | 4,077,000 | 3,847,000 |
| Income Tax | 1,254,000 | 1,143,000 | 1,177,000 | 1,099,000 | 1,299,000 |
| Net Income Continuous | 3,813,000 | 3,036,000 | 2,840,000 | 3,107,640 | 2,538,000 |
| Net Income | $3,813,000 | $3,036,000 | $2,860,000 | $2,967,000 | $2,538,000 |
| EPS Basic Total Ops | 1.14 | 0.89 | 0.82 | 0.85 | 0.72 |
| EPS Basic Continuous Ops | 1.14 | 0.89 | 0.82 | 0.88 | 0.72 |
| EPS Diluted Total Ops | 1.14 | 0.89 | 0.82 | 0.85 | 0.72 |
| EPS Diluted Continuous Ops | 1.14 | 0.89 | 0.82 | 0.88 | 0.72 |
| EBITDA(a) | $6,038,000 | $3,911,000 | $3,763,000 | $4,125,000 | $4,209,000 |